Physical Medicine and Rehabilitation for Limb-Girdle Muscular Dystrophy Medication

1. Genetics Home Reference. Limb-girdle muscular dystrophy. US National Library of Medicine. Available at https://ghr.nlm.nih.gov/condition/limb-girdle-muscular-dystrophy. 2014 Dec; Accessed: Aug 8, 2019.

2. Narayanaswami P, Weiss M, Selcen D, et al. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2014 Oct 14. 83 (16):1453-63. [QxMD MEDLINE Link]. [Full Text].

3. Leyden E. Klinik der Ruckenmarks-Krankheiten. Vol 2. Berlin:. Hirschwalk. 1876:531.

4. Möbius PJ. Ueber die hereditaren nervenkrankheiten. Volkmanns Samml Klin Notiz. 1879. 171:1505.

5. Erb W. Ueber die "Juvenile Form" der progressiven Muskelatrophie ihre Beziehungen zur sogenannten Pseudohypertrophie der Muskeln. Dtsh Archiv Klin Med. 1884. 34:467.

6. Erb W. Dystrophia muscularis progressiva. Klinische und pathologisch anatomische Studien. Dtsch Nervenh. 1891. 1:13.

7. Batten FE. The myopathies or muscular dystrophies. Q J Med. 1910. 3:313.

8. Landouzy L, Dejerine J. De La myopathic atrophique - progressive (myopathic heriditaire debutant dansleufavec, Par la free saus alteration du systeme nerveux). Services Alad Sci. 1884. 53:98.

9. Gower ER. A lecture on myopathy and a distal form. Br Med J. 1902. 2:89.

10. Spiller WG. Myopathy of the distal type and its relation to the neuroforamin of muscular atrophy (Charcot Marie Tooth Type). J Neur Med Dis. 1907. 34-14.

11. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain. 1954. 77(2):169-231. [QxMD MEDLINE Link].

12. Fanin M, Tasca E, Nascimbeni AC, et al. Sarcolemmal neuronal nitric oxide synthase defect in limb-girdle muscular dystrophy: an adverse modulating factor in the disease course?. J Neuropathol Exp Neurol. 2009 Mar 12. [QxMD MEDLINE Link].

13. Garnham C, Hanna R, Chou J, Low K, Gourlay K, Campbell R, et al. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3. Biochemistry. 2009 Feb 18. [QxMD MEDLINE Link].

14. McMillan HJ, Carter MT, Jacob PJ, et al. Homozygous contiguous gene deletion of 13q12 causing LGMD2C and ARSACS in the same patient. Muscle Nerve. 2009 Mar. 39(3):396-9. [QxMD MEDLINE Link].

15. Vuillaumier-Barrot S, Quijano-Roy S, Bouchet-Seraphin C, et al. Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype. Neuromuscul Disord. 2009 Mar. 19(3):182-8. [QxMD MEDLINE Link].

16. Rosales XQ, Tsao CY. Childhood onset of limb-girdle muscular dystrophy. Pediatr Neurol. 2012 Jan. 46(1):13-23. [QxMD MEDLINE Link].

17. Nigro V, Aurino S, Piluso G. Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. Curr Opin Neurol. 2011 Oct. 24(5):429-36. [QxMD MEDLINE Link].

18. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet. 2000 Sep 1. 9(14):2141-7. [QxMD MEDLINE Link]. [Full Text].

19. Hauser MA, Conde CB, Kowaljow V, et al. Myotilin mutation found in second pedigree with LGMD1A. Am J Hum Genet. 2002 Dec. 71(6):1428-32. [QxMD MEDLINE Link]. [Full Text].

20. Salmikangas P, van der Ven PF, Lalowski M, et al. Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly. Hum Mol Genet. 2003 Jan 15. 12(2):189-203. [QxMD MEDLINE Link]. [Full Text].

21. Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet. 2000 May 22. 9(9):1453-9. [QxMD MEDLINE Link]. [Full Text].

22. Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, et al. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry. 2002 Jul. 73(1):65-7. [QxMD MEDLINE Link]. [Full Text].

23. Messina DN, Speer MC, Pericak-Vance MA, McNally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 1997 Oct. 61(4):909-17. [QxMD MEDLINE Link]. [Full Text].

24. Speer MC, Vance JM, Grubber JM, Lennon Graham F, Stajich JM, Viles KD, et al. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am J Hum Genet. 1999 Feb. 64(2):556-62. [QxMD MEDLINE Link]. [Full Text].

25. Mascarenhas DA, Spodick DH, Chad DA, et al. Cardiomyopathy of limb-girdle muscular dystrophy. J Am Coll Cardiol. 1994 Nov 1. 24(5):1328-33. [QxMD MEDLINE Link].

26. Gigliotti F, Pizzi A, Duranti R, Gorini M, Iandelli I, Scano G. Control of breathing in patients with limb girdle dystrophy: a controlled study. Thorax. 1995 Sep. 50(9):962-8. [QxMD MEDLINE Link]. [Full Text].

27. Guyon JR, Kudryashova E, Potts A, et al. Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. Muscle Nerve. 2003 Oct. 28(4):472-83. [QxMD MEDLINE Link].

28. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995 Apr 7. 81(1):27-40. [QxMD MEDLINE Link].

29. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003 May 8. 423(6936):168-72. [QxMD MEDLINE Link].

30. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998 Sep. 20(1):31-6. [QxMD MEDLINE Link].

31. Matsuda C, Hayashi YK, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet. 2001 Aug 15. 10(17):1761-6. [QxMD MEDLINE Link]. [Full Text].

32. Rosales XQ, Moser SJ, Tran T, McCarthy B, Dunn N, Habib P, et al. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I. J Cardiovasc Magn Reson. 2011 Aug 4. 13:39. [QxMD MEDLINE Link]. [Full Text].

33. Hogarth MW, Defour A, Lazarski C, et al. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat Commun. 2019 Jun 3. 10 (1):2430. [QxMD MEDLINE Link]. [Full Text].

34. Nigro V, de Sá Moreira E, Piluso G, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet. 1996 Oct. 14(2):195-8. [QxMD MEDLINE Link].

35. Noguchi S, McNally EM, Ben Othmane K, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science. 1995 Nov 3. 270(5237):819-22. [QxMD MEDLINE Link].

36. Roberds SL, Leturcq F, Allamand V, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 1994 Aug 26. 78(4):625-33. [QxMD MEDLINE Link].

37. Moreira ES, Wiltshire TJ, Faulkner G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet. 2000 Feb. 24(2):163-6. [QxMD MEDLINE Link].

38. Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, Morgan K, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002 Mar. 70(3):663-72. [QxMD MEDLINE Link]. [Full Text].

39. Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 2001 Dec 1. 10(25):2851-9. [QxMD MEDLINE Link].

40. Krag TO, Hauerslev S, Sveen ML, Schwartz M, Vissing J. Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity. Skelet Muscle. 2011 Oct 5. 1(1):31. [QxMD MEDLINE Link]. [Full Text].

41. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet. 2002 Sep. 71(3):492-500. [QxMD MEDLINE Link]. [Full Text].

42. Schneiderman LJ, Sampson WI, Schoene WC, et al. Genetic studies of a family with two unusual autosomal dominant conditions: muscular dystrophy and Pelger-Huet anomaly. Clinical, pathologic and linkage considerations. Am J Med. 1969 Mar. 46(3):380-93. [QxMD MEDLINE Link].

43. Bacon PA, Smith B. Familial muscular dystrophy of late onset. J Neurol Neurosurg Psychiatry. 1971 Feb. 34(1):93-7. [QxMD MEDLINE Link]. [Full Text].

44. De Coster W, De Reuck J, Thiery E. A late autosomal dominant form of limb-girdle muscular dystrophy. A clinical, genetic, and morphological study. Eur Neurol. 1974. 12(3):159-72. [QxMD MEDLINE Link].

45. SHY GM, McEACHERN D. The clinical features and response to cortisone of menopausal muscular dystrophy. J Neurol Neurosurg Psychiatry. 1951 May. 14(2):101-7. [QxMD MEDLINE Link]. [Full Text].

46. Denny-Brown D. Myopathic weakness of quadriceps. Proc R Soc Med. 1939. 32:867.

47. van Wijngaarden GK, Hagen CJ, Bethlem J, Meijer AE. Myopathy of the quadriceps muscles. J Neurol Sci. 1968 Sep-Oct. 7(2):201-6. [QxMD MEDLINE Link].

48. Espir ML, Matthews WB. Hereditary quadriceps myopathy. J Neurol Neurosurg Psychiatry. 1973 Dec. 36(6):1041-5. [QxMD MEDLINE Link]. [Full Text].

49. Cossée M, Lagier-Tourenne C, Seguela C, et al. Use of SNP array analysis to identify a novel TRIM32 mutation in limb-girdle muscular dystrophy type 2H. Neuromuscul Disord. 2009 Mar 18. [QxMD MEDLINE Link].

50. De Paepe B, Velghe E, Salminen L, Toth B, Olivier P, De Bleecker JL. Diagnostic muscle biopsies in the era of genetics: the added value of myopathology in a selection of limb-girdle muscular dystrophy patients. Acta Neurol Belg. 2021 Jan 5. [QxMD MEDLINE Link].

51. Fanin M, Nascimbeni AC, Angelini C. Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients. Clin Neuropathol. 2014 May-Jun. 33(3):179-85. [QxMD MEDLINE Link].

52. Siciliano G, Simoncini C, Giannotti S, Zampa V, Angelini C, Ricci G. Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages. Acta Myol. 2015 May. 34 (1):3-8. [QxMD MEDLINE Link]. [Full Text].

53. Andries A, van Walsem MR, Frich JC. Self-reported physical activity in people with limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease in Norway. BMC Musculoskelet Disord. 2020 Apr 13. 21 (1):235. [QxMD MEDLINE Link]. [Full Text].

54. Jensen BR, Berthelsen MP, Husu E, Christensen SB, Prahm KP, Vissing J. Body weight-supported training in Becker and limb girdle 2I muscular dystrophy. Muscle Nerve. 2016 Jan 16. [QxMD MEDLINE Link].

55. Yeldan I, Gurses HN, Yuksel H. Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clin Rehabil. 2008 Aug. 22(8):741-8. [QxMD MEDLINE Link].

Vinod Sahgal, MD Chairman, Department of Physical Medicine and Rehabilitation, Director, Institute of Rehabilitation, The Cleveland Clinic Foundation

Vinod Sahgal, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation, American Congress of Rehabilitation Medicine, American Medical Association, American Spinal Injury Association

Disclosure: Nothing to disclose.

Steven I Reger, PhD, CPE Director of Rehabilitation Technology, Department of Physical Medicine and Rehabilitation, Cleveland Clinic Foundation; Professor, Department of Industrial and Manufacturing Engineering, Cleveland State University

Steven I Reger, PhD, CPE is a member of the following medical societies: American Academy of Orthotists and Prosthetists, Association for Academic Psychiatry, Institute of Electrical and Electronics Engineers, New York Academy of Sciences, Orthopaedic Research Society, Rehabilitation Engineering and Assistive Technology Society of North America, Society for Biomaterials

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Kat Kolaski, MD Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine

Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Stephen Kishner, MD, MHA Clinical Professor, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Elizabeth A Moberg-Wolff, MD Medical Director, Pediatric Rehabilitation Medicine Associates

Elizabeth A Moberg-Wolff, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Merz.

The authors and editors of Medscape Reference wish to thank Suneet Sahgal, MD, Staff Physician, Department of Physical Medicine and Rehabilitation, Northwestern University Medical School, for his previous contribution to this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article